Wilen Investment Management Trimmed Standex Intl Cp (SXI) Stake as Share Value Declined; As Abbvie (ABBV) Market Valuation Rose, Howe & Rusling Has Cut Its Holding

February 18, 2018 - By Maria Brooks

Wilen Investment Management Corp decreased its stake in Standex Intl Cp (SXI) by 8.63% based on its latest 2017Q3 regulatory filing with the SEC. Wilen Investment Management Corp sold 9,392 shares as the company’s stock declined 6.55% while stock markets rallied. The institutional investor held 99,464 shares of the industrial machinery and components company at the end of 2017Q3, valued at $10.49M, down from 108,856 at the end of the previous reported quarter. Wilen Investment Management Corp who had been investing in Standex Intl Cp for a number of months, seems to be less bullish one the $1.27B market cap company. The stock increased 0.36% or $0.35 during the last trading session, reaching $98.7. About 159,121 shares traded or 237.48% up from the average. Standex International Corporation (NYSE:SXI) has risen 11.03% since February 18, 2017 and is uptrending. It has underperformed by 5.67% the S&P500.

Howe & Rusling Inc decreased its stake in Abbvie Inc (ABBV) by 7.15% based on its latest 2017Q3 regulatory filing with the SEC. Howe & Rusling Inc sold 9,212 shares as the company’s stock rose 6.17% with the market. The institutional investor held 119,548 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $10.62 million, down from 128,760 at the end of the previous reported quarter. Howe & Rusling Inc who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $189.34 billion market cap company. The stock increased 3.22% or $3.7 during the last trading session, reaching $118.6. About 8.83 million shares traded or 48.72% up from the average. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since February 18, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Since September 11, 2017, it had 0 insider buys, and 5 selling transactions for $25.59 million activity. Gosebruch Henry O sold $1.66M worth of AbbVie Inc. (NYSE:ABBV) on Monday, October 30. 6,699 AbbVie Inc. (NYSE:ABBV) shares with value of $589,512 were sold by Michael Robert A.. Schumacher Laura J also sold $14.07M worth of AbbVie Inc. (NYSE:ABBV) on Thursday, December 14. 8,300 shares valued at $705,655 were sold by SALEKI-GERHARDT AZITA on Monday, September 11.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 9 Hold. Therefore 48% are positive. Abbvie Inc had 78 analyst reports since July 21, 2015 according to SRatingsIntel. Jefferies maintained it with “Buy” rating and $130.0 target in Tuesday, January 16 report. TheStreet upgraded the stock to “Buy” rating in Tuesday, August 11 report. On Monday, October 31 the stock rating was downgraded by Credit Suisse to “Neutral”. The stock of AbbVie Inc. (NYSE:ABBV) earned “Neutral” rating by Citigroup on Monday, November 28. BMO Capital Markets downgraded the shares of ABBV in report on Tuesday, January 30 to “Underperform” rating. As per Friday, January 26, the company rating was maintained by Cowen & Co. The company was maintained on Tuesday, September 5 by Cowen & Co. On Wednesday, June 8 the stock rating was downgraded by Morgan Stanley to “Equal-Weight”. The rating was maintained by Jefferies with “Buy” on Monday, July 17. The company was maintained on Friday, April 28 by BMO Capital Markets.

Howe & Rusling Inc, which manages about $798.49 million and $540.49M US Long portfolio, upped its stake in Cigna Corporation (NYSE:CI) by 2,246 shares to 2,384 shares, valued at $446,000 in 2017Q3, according to the filing. It also increased its holding in Pepsico Inc (NYSE:PEP) by 3,212 shares in the quarter, for a total of 87,135 shares, and has risen its stake in Alphabet Inc.

Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.15, from 1 in 2017Q2. It dived, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Horseman Mngmt Limited invested 0.41% of its portfolio in AbbVie Inc. (NYSE:ABBV). King Luther Capital Corporation invested 1.92% in AbbVie Inc. (NYSE:ABBV). Regal Invest Advsrs Ltd Liability Co has 84,728 shares. Point72 Asia (Hong Kong) Limited has 1,695 shares. Employees Retirement Sys Of Texas has 0.29% invested in AbbVie Inc. (NYSE:ABBV). Hilltop Inc holds 0.98% or 36,357 shares. 6,813 are owned by Ftb. The New York-based Orbimed Advsr Limited has invested 1.67% in AbbVie Inc. (NYSE:ABBV). Gradient Invests Lc stated it has 103,962 shares. Zevin Asset Mngmt Lc holds 2.28% or 109,428 shares. South Texas Money Mgmt Limited owns 0.1% invested in AbbVie Inc. (NYSE:ABBV) for 24,653 shares. Buckingham holds 43,708 shares or 0.86% of its portfolio. Todd Asset Mgmt Lc invested 0.58% in AbbVie Inc. (NYSE:ABBV). Boston Private Wealth Ltd Co has invested 1.51% in AbbVie Inc. (NYSE:ABBV). New Jersey-based Tsp Capital Mgmt Gp Ltd Limited Liability Company has invested 0.31% in AbbVie Inc. (NYSE:ABBV).

Wilen Investment Management Corp, which manages about $240.00M and $164.26 million US Long portfolio, upped its stake in Kraton Perform (NYSE:KRA) by 21,521 shares to 98,363 shares, valued at $3.89 million in 2017Q3, according to the filing.

Among 6 analysts covering Standex Int’l Corp. (NYSE:SXI), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Standex Int’l Corp. had 8 analyst reports since August 11, 2015 according to SRatingsIntel. As per Tuesday, August 11, the company rating was upgraded by Zacks. The firm has “Market Perform” rating by CJS Securities given on Monday, December 12. Wunderlich maintained Standex International Corporation (NYSE:SXI) rating on Thursday, August 27. Wunderlich has “Buy” rating and $98.0 target. The stock of Standex International Corporation (NYSE:SXI) has “Neutral” rating given on Monday, December 19 by Sidoti. C.L. King initiated Standex International Corporation (NYSE:SXI) rating on Wednesday, November 29. C.L. King has “Buy” rating and $116.0 target. FBR Capital maintained Standex International Corporation (NYSE:SXI) on Monday, July 17 with “Buy” rating.

Since August 30, 2017, it had 0 insider purchases, and 1 sale for $189,288 activity.

Investors sentiment decreased to 1.06 in 2017 Q3. Its down 0.03, from 1.09 in 2017Q2. It worsened, as 8 investors sold SXI shares while 42 reduced holdings. 17 funds opened positions while 36 raised stakes. 10.01 million shares or 0.78% less from 10.09 million shares in 2017Q2 were reported. Gabelli Funds Llc accumulated 0.04% or 58,000 shares. 25,649 were reported by Parametric Limited Liability Company. Comerica Bank holds 0.04% or 53,060 shares. Segall Bryant And Hamill Llc invested in 0.22% or 88,787 shares. Wells Fargo Mn stated it has 0% of its portfolio in Standex International Corporation (NYSE:SXI). Keybank Natl Association Oh invested 0% of its portfolio in Standex International Corporation (NYSE:SXI). Renaissance Technology Lc reported 0.01% in Standex International Corporation (NYSE:SXI). Millennium Mngmt Ltd Llc reported 0% of its portfolio in Standex International Corporation (NYSE:SXI). Swiss Bank accumulated 21,200 shares or 0% of the stock. Arizona State Retirement Sys holds 0.01% or 6,640 shares in its portfolio. Retail Bank Of Montreal Can reported 523 shares. Blackrock Inc owns 1.54 million shares. Public Sector Pension Investment Board stated it has 0% in Standex International Corporation (NYSE:SXI). Geode Cap Mngmt Ltd Liability holds 0% or 102,068 shares in its portfolio. Advsr Asset Mngmt Inc reported 0.01% in Standex International Corporation (NYSE:SXI).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Maria Brooks

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: